Advertisement

Prediabetes pp 45-51 | Cite as

Insulin Autoantibodies in Pre-Diabetes

  • William J. Riley
  • Mark A. Atkinson
  • Noel K. MacLaren
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 246)

Abstract

Evidence that insulin dependent diabetes mellitus (IDD) is an autoimmune disease has accumulated since autoantibodies to cytoplasmic antigens (ICA)in the pancreatic islet cell were first described a decade ago (1). In addition, other autoantibodies reactive to cell surface antigens of islet cells (ICSA) have been identified using various methods and sources of islet tissue (2–3). The frequencies of these islet reactive antibodies are highest near the time of diagnosis of IDD and fall progressively thereafter. Recently, several reports have observed that ICA can also present years before the onset of clinical diabetes and may, therefore, serve as markers for the autoimmune destruction of beta cells (4–5).

Keywords

Atrophic Gastritis Pernicious Anemia Insulin Binding Exogenous Insulin Islet Cell Antibody 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lendrum, R., Walker, G., Cudworth, A.G., et al., 1976, Antibodies in diabetes mellitus. Lancet 2: 1273–1276.PubMedCrossRefGoogle Scholar
  2. 2.
    Maclaren, N.K., Huang, S., Fogh, J., 1975, Antibody to cultured human insulinoma cells in insulin-dependent diabetes. Lancet 1: 997–999.PubMedCrossRefGoogle Scholar
  3. 3.
    Lernmark, A., Freedman, Z., Hoffman, C., et al., 1978, Islet-cell surface antibodies in juvenile diabetes mellitus. N Engl J Med 229: 375–380.CrossRefGoogle Scholar
  4. 4.
    Gorsuch, A.N., Spencer, K.M., Lister, J., et al., 1981, Evidence for a long pre-diabetic period in Type I (insulin-dependent) diabetes mellitus. Lancet 2: 1363–1365.PubMedCrossRefGoogle Scholar
  5. 5.
    Srikanta, S., Ganda, O.P., Eisenbarth, G.S., Soeldner, J.S., 1983, Islet cell antibodies and beta-cell function in monozygotic triplets and twins initially discordant for Type I diabetes mellitus. N Engl J Med 308: 322–325.PubMedCrossRefGoogle Scholar
  6. 6.
    Schernthaner, G., Borkenstein, M., Fink, M., et al., 1983, Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR typed insulin-dependent diabetic individuals. Diabetes Care 6: 43–48.PubMedGoogle Scholar
  7. 7.
    Palmer, J.P., Asplin, C.M., Clemons, P., et al., 1983, Insulin antibodies in insulin dependent diabetes before insulin treatment. Science 222: 1337–1339.PubMedCrossRefGoogle Scholar
  8. 8.
    Neufeld, M., Maclaren, N.K., Riley, W.J., et al., 1980, Islet cell and other organ-specific antibodies in U.S. caucasions and Blacks with IDDM. Diabetes 29: 589–592.PubMedCrossRefGoogle Scholar
  9. 9.
    Soeldner, J.S., Tuttleman, M., Srikanta, S., et al., 1985, Insulin dependent diabetes mellitus and autoimmunity: Islet-cell autoantibodies, insulin autoantibodies, and beta-cell failure. N Engl J Med 313: 893–894.PubMedCrossRefGoogle Scholar
  10. 10.
    Riley, W.J., Toskes, P.P., Maclaren, N.K., Silverstein, J.H., 1982, Predictive value of gastric parietal cell autoantibodies as a marker for gastric and hematologic abnormalities associated with insulin dependent diabetes. Diabetes 31: 1051–1055.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • William J. Riley
    • 1
  • Mark A. Atkinson
    • 1
  • Noel K. MacLaren
    • 1
  1. 1.Departments of Pathology and PediatricsUniversity Of Florida College of MedicineGainesvilleUSA

Personalised recommendations